CN109001177A - The detection method of tyrosine in a kind of urine - Google Patents
The detection method of tyrosine in a kind of urine Download PDFInfo
- Publication number
- CN109001177A CN109001177A CN201810611783.5A CN201810611783A CN109001177A CN 109001177 A CN109001177 A CN 109001177A CN 201810611783 A CN201810611783 A CN 201810611783A CN 109001177 A CN109001177 A CN 109001177A
- Authority
- CN
- China
- Prior art keywords
- tyrosine
- silver
- mol
- solution
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 title claims abstract description 83
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 title claims abstract description 82
- 210000002700 urine Anatomy 0.000 title claims abstract description 45
- 238000001514 detection method Methods 0.000 title claims abstract description 18
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 61
- 238000001069 Raman spectroscopy Methods 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 31
- 229910052709 silver Inorganic materials 0.000 claims abstract description 27
- 239000004332 silver Substances 0.000 claims abstract description 27
- 230000003075 superhydrophobic effect Effects 0.000 claims abstract description 21
- 238000006243 chemical reaction Methods 0.000 claims abstract description 20
- 239000000243 solution Substances 0.000 claims description 33
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 19
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 16
- 239000000987 azo dye Substances 0.000 claims description 16
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims description 16
- 238000012360 testing method Methods 0.000 claims description 16
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 15
- PLKATZNSTYDYJW-UHFFFAOYSA-N azane silver Chemical compound N.[Ag] PLKATZNSTYDYJW-UHFFFAOYSA-N 0.000 claims description 14
- 238000001027 hydrothermal synthesis Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 9
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 9
- WCDSVWRUXWCYFN-UHFFFAOYSA-N 4-aminobenzenethiol Chemical compound NC1=CC=C(S)C=C1 WCDSVWRUXWCYFN-UHFFFAOYSA-N 0.000 claims description 8
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 8
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 8
- 235000010288 sodium nitrite Nutrition 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 230000005284 excitation Effects 0.000 claims description 6
- 238000000479 surface-enhanced Raman spectrum Methods 0.000 claims description 6
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000005352 clarification Methods 0.000 claims description 4
- 150000008049 diazo compounds Chemical class 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000001237 Raman spectrum Methods 0.000 claims description 3
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 238000001228 spectrum Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- DZGWFCGJZKJUFP-UHFFFAOYSA-N Tyramine Natural products NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000000284 resting effect Effects 0.000 claims 1
- 229960003732 tyramine Drugs 0.000 claims 1
- DZGWFCGJZKJUFP-UHFFFAOYSA-O tyraminium Chemical compound [NH3+]CCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-O 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 abstract description 8
- 238000006149 azo coupling reaction Methods 0.000 abstract description 6
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 230000001595 contractor effect Effects 0.000 abstract description 2
- 206010028980 Neoplasm Diseases 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 238000001556 precipitation Methods 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229910001961 silver nitrate Inorganic materials 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- -1 azo compound Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- DOBUSJIVSSJEDA-UHFFFAOYSA-L 1,3-dioxa-2$l^{6}-thia-4-mercuracyclobutane 2,2-dioxide Chemical compound [Hg+2].[O-]S([O-])(=O)=O DOBUSJIVSSJEDA-UHFFFAOYSA-L 0.000 description 1
- 101710134784 Agnoprotein Proteins 0.000 description 1
- 206010001557 Albinism Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 230000005653 Brownian motion process Effects 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 201000011252 Phenylketonuria Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000005537 brownian motion Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 229910000361 cobalt sulfate Inorganic materials 0.000 description 1
- 229940044175 cobalt sulfate Drugs 0.000 description 1
- KTVIXTQDYHMGHF-UHFFFAOYSA-L cobalt(2+) sulfate Chemical compound [Co+2].[O-]S([O-])(=O)=O KTVIXTQDYHMGHF-UHFFFAOYSA-L 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910001987 mercury nitrate Inorganic materials 0.000 description 1
- 229910000370 mercury sulfate Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- KBJMLQFLOWQJNF-UHFFFAOYSA-N nickel(ii) nitrate Chemical compound [Ni+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O KBJMLQFLOWQJNF-UHFFFAOYSA-N 0.000 description 1
- DRXYRSRECMWYAV-UHFFFAOYSA-N nitrooxymercury Chemical compound [Hg+].[O-][N+]([O-])=O DRXYRSRECMWYAV-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
- G01N21/658—Raman scattering enhancement Raman, e.g. surface plasmons
Landscapes
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明涉及一种尿液中酪氨酸的检测方法,具体是一种表面增强拉曼光谱检测方法。将偶氮化的酪氨酸与立方纳米银混合后滴在超疏水银膜上,待其干后在拉曼光谱仪下检测偶氮化酪氨酸的拉曼信号。该方法的优点在于利用立方纳米银的增强效果和超疏水银膜的收缩作用结合酪氨酸的重氮偶联反应来间接检测酪氨酸的浓度。该方法对酪氨酸溶液的检测极限浓度达到10‑ 12mol/L,对尿液中的酪氨酸的检测极限浓度达到10‑8mol/L,实现超痕量检测,具有较高的准确性和灵敏度。
The invention relates to a method for detecting tyrosine in urine, in particular to a method for detecting surface-enhanced Raman spectroscopy. Azotyrosine is mixed with cubic nano-silver and dropped on the superhydrophobic silver film, and the Raman signal of azotyrosine is detected under a Raman spectrometer after it dries. The advantage of this method is that the concentration of tyrosine can be indirectly detected by using the enhancement effect of cubic nano-silver and the contraction effect of superhydrophobic silver film combined with the diazo coupling reaction of tyrosine. The method has a detection limit concentration of 10 ‑ 12 mol/L for tyrosine solution and 10 ‑8 mol/L for tyrosine in urine, realizing ultra-trace detection with high accuracy. sex and sensitivity.
Description
技术领域technical field
本发明涉及尿液中氨基酸检测技术领域,特别涉及一种尿液中酪氨酸的检测方法。The invention relates to the technical field of amino acid detection in urine, in particular to a method for detecting tyrosine in urine.
背景技术Background technique
酪氨酸是人体重要的半必需氨基酸,它是人体中合成多种蛋白类激素的重要原料,是机体生物合成儿茶酚胺的前身物质。因酪氨酸代谢异常导致的疾病包括白化病、阿尔茨海默症、苯丙酮酸尿症、白癜风和帕金森等。在正常个体中其含量相对稳定,而在肿瘤患者体液中,酪氨酸含量与健康人相比会有比较大的差异。体液代谢产物同样可以作为早期发现和监测多种肿瘤进程的标志物,肿瘤病人尿液中酚类代谢物排出量增加。在酪氨酸的研究中,以血清中酪氨酸及其代谢产物的研究相对较多,而对人体尿液中酪氨酸研究相对较少。血清肿瘤标志物存在操作繁琐,成本高,有创性,早期检出率不高等缺点。因此,探索酪氨酸含量的分析新技术并应用于尿液样品测定,对癌症的辅助诊断、治疗和监测具有十分重要的临床意义。Tyrosine is an important semi-essential amino acid for the human body. It is an important raw material for the synthesis of various protein hormones in the human body and a precursor substance for the biosynthesis of catecholamines in the body. Diseases caused by abnormal tyrosine metabolism include albinism, Alzheimer's disease, phenylketonuria, vitiligo, and Parkinson's, among others. Its content is relatively stable in normal individuals, but in the body fluids of tumor patients, the content of tyrosine will be quite different from that of healthy people. Body fluid metabolites can also be used as markers for early detection and monitoring of various tumor processes, and the excretion of phenolic metabolites in the urine of tumor patients increases. In the study of tyrosine, there are relatively many studies on tyrosine in serum and its metabolites, but there are relatively few studies on tyrosine in human urine. Serum tumor markers have disadvantages such as cumbersome operation, high cost, invasiveness, and low early detection rate. Therefore, it is of great clinical significance to explore the new analysis technology of tyrosine content and apply it to the determination of urine samples for the auxiliary diagnosis, treatment and monitoring of cancer.
表面增强拉曼散射(SERS)技术因其高灵敏度,高选择性,非破坏性,操作简单等优点而被广泛应用。立方纳米银有8个尖角,12条棱边,由于热点效应,使光场局域于边角处,极大增强了该处的电场强度,其规整的平面结构使立方纳米银具有分散性较好的特点,这些特点使得立方纳米银基底具有很好的增强效果。超疏水银膜的收缩过程,可以富集分析物以达到痕量检测。可以实时监测分析物与纳米银胶体混合后在超疏水性银膜上的吸附的动态过程。Surface-enhanced Raman scattering (SERS) technology is widely used because of its high sensitivity, high selectivity, non-destructive, simple operation and so on. Cubic nano-silver has 8 sharp corners and 12 edges. Due to the hot spot effect, the light field is localized at the corner, which greatly enhances the electric field intensity there. Its regular planar structure makes cubic nano-silver dispersive. Better characteristics, these characteristics make the cubic nano silver substrate have a good reinforcing effect. The shrinking process of the superhydrophobic silver film can enrich analytes for trace detection. The dynamic process of the adsorption of the analyte on the superhydrophobic silver film after mixing with the nano-silver colloid can be monitored in real time.
中国专利号(CN 107014806A)公开了一种尿液中酪氨酸的检测试纸,利用生物复合酶催化酪氨酸发生特异性显色反应;中国专利(CN 201510962013.1)公开了一种用于检测人体尿液中酪氨酸类肿瘤标志物的试剂,由硝酸汞溶液、硫酸汞溶液、硝酸镍溶液、硫酸钴溶液组成;中国专利(CN 201510537446.2)公开了一种对羟基苯丙氨酸酪氨酸尿液检测试剂,试剂含有H+、Ni2+、Hg+、NO3-离子和磷钼酸和/或磷钼酸可溶性盐。现有的尿液中的酪氨酸的检测的专利的反应原理一般都是通过显色反应,这些方法仍存在许多不足之处,灵敏度低,检测结果不准确,容易受尿液颜色的干扰。Chinese Patent No. (CN 107014806A) discloses a detection test paper for tyrosine in urine, which utilizes biological complex enzymes to catalyze tyrosine to generate specific color reaction; Chinese Patent (CN 201510962013.1) discloses a test paper for detecting human A reagent for tyrosine tumor markers in urine is composed of mercury nitrate solution, mercury sulfate solution, nickel nitrate solution, and cobalt sulfate solution; Chinese patent (CN 201510537446.2) discloses a p-hydroxyphenylalanine tyrosine Urine detection reagent, the reagent contains H + , Ni 2+ , Hg + , NO 3- ions and phosphomolybdic acid and/or soluble salt of phosphomolybdic acid. The existing patented reaction principle for the detection of tyrosine in urine is generally through color reaction. These methods still have many shortcomings, such as low sensitivity, inaccurate detection results, and easy to be interfered by urine color.
发明内容Contents of the invention
为了解决上述问题,本发明提供一种通过重氮偶联反应,将偶氮化的酪氨酸与立方纳米银混合后滴在超疏水银膜上,利用表面增强拉曼光谱技术检测尿液中的酪氨酸的新方法。本发明快速简单,灵敏度高,立方纳米银拉曼基底材料形貌均匀,拉曼活性高。In order to solve the above problems, the present invention provides a method of mixing azotized tyrosine with cubic nano-silver and dropping it on the super-hydrophobic silver film through diazo coupling reaction, and using surface-enhanced Raman spectroscopy to detect urine A new method of tyrosine. The invention is fast and simple, has high sensitivity, uniform shape of cubic nano-silver Raman base material, and high Raman activity.
本发明的目的是通过以下技术方案实现的:The purpose of the present invention is achieved through the following technical solutions:
一种尿液中的酪氨酸检测方法,包括以下步骤:A method for detecting tyrosine in urine, comprising the following steps:
(1)由一步水热法制备立方纳米银,得到粒径大小分布均匀的立方纳米银;(1) cubic nano-silver is prepared by a one-step hydrothermal method to obtain cubic nano-silver with uniform particle size distribution;
(2)将对氨基苯硫酚与亚硝酸钠在冰浴条件下反应,生成重氮化合物,再加入碳酸钠调节pH使整个溶液处于碱性环境下,与5-7个不同浓度梯度的酪氨酸混合生成偶氮染料;(2) React p-aminothiophenol with sodium nitrite under ice bath conditions to generate a diazo compound, then add sodium carbonate to adjust the pH so that the entire solution is in an alkaline environment, and react with 5-7 phenols with different concentration gradients. Amino acid mixed to form azo dyes;
(3)制备超疏水银膜;(3) prepare superhydrophobic silver film;
(4)取步骤(2)制备的不同浓度梯度的偶氮染料分别与步骤(1)制备的立方纳米银混合,滴在步骤(3)中的超疏水银膜上,静置1000s-2000s后使用雷尼绍拉曼光谱仪进行拉曼信号的检测,采集偶氮染料的SERS光谱,建立拉曼光谱强度-酪氨酸浓度的关系绘制标准曲线;(4) Mix the azo dyes with different concentration gradients prepared in step (2) with the cubic nano-silver prepared in step (1), drop them on the superhydrophobic silver film in step (3), and let stand for 1000s-2000s Use the Renishaw Raman spectrometer to detect the Raman signal, collect the SERS spectrum of the azo dye, and establish the relationship between the intensity of the Raman spectrum and the concentration of tyrosine to draw a standard curve;
(5)检测未知样品浓度:将未知浓度的待检测的尿液与步骤(1)制备的立方纳米银混合,滴在超疏水银膜上,待其干后使用雷尼绍拉曼光谱仪进行测试,得到拉曼光谱谱线强度,通过公式算出酪氨酸的浓度。(5) Detection of unknown sample concentration: Mix the unknown concentration of urine to be detected with the cubic nano-silver prepared in step (1), drop it on the superhydrophobic silver film, and use the Renishaw Raman spectrometer to test after it dries , to obtain the Raman spectral line intensity, and calculate the concentration of tyrosine by the formula.
优选的,所述步骤(4)的静置时间为1500s。Preferably, the standing time of the step (4) is 1500s.
进一步的,步骤(1)的具体步骤为:首先配置银氨溶液,然后将5mL银氨溶液与5mL浓度为20-50mmol/L的十六烷基三甲基溴化铵、10mL浓度为1-10mmol/L的葡萄糖溶液充分混合后,将上述混合液倒入水热反应釜中置于烘箱中加热反应,反应时间8小时,反应温度为120℃,得到纳米银胶体。Further, the specific steps of step (1) are: first configure the silver ammonia solution, then mix 5mL silver ammonia solution with 5mL concentration of cetyltrimethylammonium bromide of 20-50mmol/L, 10mL concentration of 1- After the 10mmol/L glucose solution was fully mixed, the above mixed solution was poured into a hydrothermal reaction kettle and placed in an oven for heating reaction. The reaction time was 8 hours and the reaction temperature was 120°C to obtain nano-silver colloid.
进一步的,步骤(2)的具体步骤为:将1mL对氨基苯硫酚(10-3mol/L)与1mL亚硝酸钠5%-8%(质量分数)在冰浴下反应生成重氮化合物,再加入1mL碳酸钠8%-10%(质量分数)调节pH使整个溶液处于碱性条件下,与2mL不同浓度的酪氨酸混合生成偶氮染料。Further, the specific steps of step (2) are: react 1mL p-aminothiophenol (10 -3 mol/L) with 1mL sodium nitrite 5%-8% (mass fraction) in an ice bath to generate a diazo compound , and then add 1 mL of sodium carbonate 8%-10% (mass fraction) to adjust the pH to make the whole solution under alkaline conditions, and mix with 2 mL of tyrosine of different concentrations to form azo dyes.
进一步的,步骤(3)具体步骤为:超疏水银膜是通过银镜反应在玻璃片上镀一层银,首先配置银氨溶液,将一定量的氨水加入到50mL 2%(质量分数)的AgNO3溶液中,再加入2mL 6%(质量分数)葡萄糖溶液于银氨溶液中,然后将清洗干净的玻璃板放入上述溶液中于75℃水浴加热10分钟后,将制备好的银膜浸泡于十二烷基硫醇的乙醇溶液(10-3mol/L)中12小时后,从溶液中取出风干。Further, the specific steps of step (3) are: the superhydrophobic silver film is to coat a layer of silver on the glass sheet through the silver mirror reaction, first configure the silver ammonia solution, and add a certain amount of ammonia water to 50mL of 2% (mass fraction) AgNO 3 solution, then add 2mL of 6% (mass fraction) glucose solution to the silver ammonia solution, then put the cleaned glass plate into the above solution and heat it in a water bath at 75°C for 10 minutes, then soak the prepared silver film in After 12 hours in ethanol solution (10 -3 mol/L) of dodecylmercaptan, it was taken out from the solution and air-dried.
进一步的,步骤(4)中,所述5-7个浓度梯度的酪氨酸溶液样品的浓度变化值为10- 6mol/L-10-12mol/L。Further, in step (4), the concentration change value of the 5-7 concentration gradient tyrosine solution samples is 10-6 mol/L - 10-12 mol/L.
进一步的,步骤(4)中酪氨酸的浓度为10-6mol/L,10-7mol/L,10-8mol/L,10-9mol/L,10-10mol/L,10-11mol/L,10-12mol/L。Further, the concentration of tyrosine in step (4) is 10 -6 mol/L, 10 -7 mol/L, 10 -8 mol/L, 10 -9 mol/L, 10 -10 mol/L, 10 -11 mol/L, 10 -12 mol/L.
进一步的,所述立方纳米银的粒径为40-80nm。Further, the particle size of the cubic nano silver is 40-80nm.
进一步的,拉曼测试的激发波长为785nm。Further, the excitation wavelength of the Raman test is 785nm.
与现有方法相比,本发明具有的有益效果在于:Compared with existing methods, the present invention has the beneficial effects of:
1.本发明采用酪氨酸的重氮偶联反应间接检测酪氨酸的浓度,得到的偶氮染料作为探针分子,通过偶氮染料的特征峰来间接判断酪氨酸的存在。该方法简便、高效、灵敏度高,不仅仅能定性分析出尿液中酪氨酸的存在,还能定量检测人尿液中酪氨酸的含量,对于肿瘤病人的早期筛查存在潜在价值。1. The present invention uses the diazo coupling reaction of tyrosine to indirectly detect the concentration of tyrosine, and the obtained azo dye is used as a probe molecule, and the presence of tyrosine is indirectly judged through the characteristic peak of the azo dye. The method is simple, efficient, and highly sensitive. It can not only qualitatively analyze the presence of tyrosine in urine, but also quantitatively detect the content of tyrosine in human urine. It has potential value for early screening of tumor patients.
2.本发明采用一步水热法制备出颗粒大小均匀的立方纳米银基底,立方纳米银有8个尖角,12条棱边,由于热点效应,使光场局域于边角处,极大增强了该处的电场强度,产生热点效应,这使它具有较高的活性和增强效果。2. The present invention adopts a one-step hydrothermal method to prepare a cubic nano-silver substrate with uniform particle size. The cubic nano-silver has 8 sharp corners and 12 edges. Due to the hot spot effect, the light field is localized at the corners, which is extremely large. The electric field strength at this place is enhanced to produce a hot spot effect, which makes it have higher activity and enhancement effect.
3.本发明选用超疏水银膜作为衬底进行拉曼检测。利用超疏水银膜的收缩作用提高了酪氨酸的检测极限。因为超疏水银膜的收缩过程,可以将扩散分析物富集以检测痕量分子。同时,探针分子在超疏水银膜上的收缩过程是一个从湿态到干态的动态过程,干态是最佳的检测状态。3. The present invention selects the superhydrophobic silver film as the substrate for Raman detection. The detection limit of tyrosine was improved by utilizing the contraction effect of the superhydrophobic silver film. Because of the shrinkage process of the superhydrophobic silver film, diffuse analytes can be enriched for detection of trace molecules. At the same time, the shrinking process of probe molecules on the superhydrophobic silver film is a dynamic process from wet state to dry state, and the dry state is the best detection state.
附图说明Description of drawings
图1是实施例1的立方纳米银的透射电镜(TEM)图;Fig. 1 is the transmission electron microscope (TEM) figure of the cubic nano-silver of embodiment 1;
图2是实施例1不同时间段的酪氨酸偶氮染料(10-6mol/L)的动态拉曼光谱图;Fig. 2 is the dynamic Raman spectrogram of the tyrosine azo dye (10 -6 mol/L) of different time periods in Example 1;
图3是实施例2的酪氨酸偶氮染料三个特征峰强度随时间变化图;Fig. 3 is three characteristic peak intensity changes with time of the tyrosine azo dye of embodiment 2;
图4是实施例2的不同浓度(10-6mol/L,10-7mol/L,10-8mol/L,10-9mol/L,10-10mol/L,10-11mol/L,10-12mol/L)酪氨酸的表面增强拉曼光谱图;Figure 4 is the different concentrations of Example 2 (10 -6 mol/L, 10 -7 mol/L, 10 -8 mol/L, 10 -9 mol/L, 10 -10 mol/L, 10 -11 mol/L L, 10 -12 mol/L) the surface enhanced Raman spectrogram of tyrosine;
图5是实施例1的偶氮化合物的特征峰强度(1142±2cm-1,1393±2cm-11432±2cm-1)与酪氨酸浓度的线性关系示意图;Fig. 5 is a schematic diagram of the linear relationship between the characteristic peak intensity (1142±2cm -1 , 1393±2cm -1 1432±2cm -1 ) of the azo compound of Example 1 and the concentration of tyrosine;
图6是应用实施例1的不同浓度(10-4mol/L,10-5mol/L,10-6mol/L,10-7mol/L,10- 8mol/L)尿液中的酪氨酸的偶氮盐的表面增强拉曼光谱;Fig. 6 is the concentration (10 -4 mol/L, 10 -5 mol/L, 10 -6 mol/L, 10 -7 mol/L, 10 - 8 mol/L) in urine of application example 1 Surface-enhanced Raman spectroscopy of azo salts of tyrosine;
图7是应用实施例1的尿液中的偶氮化合物特征峰强度1393±2cm-1与尿液中酪氨酸浓度的线性关系示意图。Fig. 7 is a schematic diagram of the linear relationship between the characteristic peak intensity of azo compounds in urine at 1393±2cm -1 and the concentration of tyrosine in urine according to Example 1.
具体实施方式Detailed ways
为了更好的理解本发明,下面通过实施例对本发明进一步说明,实施例只用于解释本发明,并不会对本发明构成任何限定。In order to better understand the present invention, the present invention will be further described through the following examples, which are only used to explain the present invention and do not constitute any limitation to the present invention.
以下实施例用于说明本发明,但不用来限制本发明的范围。若未特别指明,实施例中所用的技术手段为本领域技术人员所熟知的常规手段,所用原料均为市售商品。The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art, and the raw materials used are all commercially available products.
实施例1Example 1
(1)水热法制备立方纳米银(1) Preparation of cubic nano-silver by hydrothermal method
首先配置银氨溶液,取0.01mol/L的硝酸银水溶液,滴加稀氨水2%(质量分数,下同)溶液从澄清到沉淀再到沉淀恰好消失为止。5mL配好的银氨溶液和5mL十六烷基三甲基溴化铵(20mmol/L)再加上10mL葡萄糖溶液(10mmol/L),充分搅拌混合均匀后倒入25mL的水热反应釜中,将反应釜置于烘箱中120℃反应8h。反应结束后自然冷却至室温,通过10000rpm离心20min,洗涤三次,除去多余的十六烷基三甲基溴化铵。得到直径为75nm,颗粒大小均匀的立方纳米银,如图1所示。First configure silver ammonia solution, take 0.01mol/L silver nitrate aqueous solution, add dropwise dilute ammonia water 2% (mass fraction, the same below) solution from clarification to precipitation until the precipitation just disappears. 5mL silver ammonia solution and 5mL cetyltrimethylammonium bromide (20mmol/L) plus 10mL glucose solution (10mmol/L), fully stirred and mixed evenly, poured into a 25mL hydrothermal reaction kettle , put the reactor in an oven at 120°C for 8h. After the reaction was completed, it was naturally cooled to room temperature, centrifuged at 10,000 rpm for 20 min, and washed three times to remove excess cetyltrimethylammonium bromide. A cubic nanosilver with a diameter of 75nm and uniform particle size was obtained, as shown in FIG. 1 .
(2)酪氨酸的重氮偶联反应(2) Diazo coupling reaction of tyrosine
在冰浴中,首先取1mL对氨基苯硫酚(10-3mol/L)于试管中,加1mL亚硝酸钠水溶液(5%),搅拌1min.然后将1mL碳酸钠(8%)与2mL浓度为10-6mol/L的酪氨酸同时快速加进试管中搅拌反应1min,生成偶氮染料。结构如下所示:In an ice bath, first take 1 mL of p-aminothiophenol (10 -3 mol/L) in a test tube, add 1 mL of sodium nitrite aqueous solution (5%), and stir for 1 min. Then mix 1 mL of sodium carbonate (8%) with 2 mL Tyrosine with a concentration of 10 -6 mol/L was quickly added into the test tube at the same time and stirred for 1 min to generate an azo dye. The structure looks like this:
(3)酪氨酸浓度的测定(3) Determination of tyrosine concentration
取1.5μL偶氮化的酪氨酸与立方纳米银混合后滴加在超疏水银膜上,使用雷尼绍拉曼光谱仪进行拉曼信号的检测,激发波长为785nm,采集偶氮盐的SERS光谱。用10-6mol/L偶氮化的酪氨酸作为探针分子,从湿态测到干态,发现探针分子处于干态的时候拉曼信号是最稳定的,如图2所示。在1000s前,几乎没有拉曼信号,这是因为在初始阶段,溶胶中的纳米粒子在无规则的做布朗运动,这时处于湿态;1500s的时候拉曼强度达到最大,但是随后拉曼强度又急速下降,这个过程时间太短而不能准确测量探针分子信号;静置1500s时,拉曼信号最强,2000s后,探针分子的拉曼信号处于一个平稳状态,峰强处于一个平台不再波动,这时处于干态。Take 1.5 μL of azotized tyrosine mixed with cubic nano-silver and drop it on the superhydrophobic silver film, use Renishaw Raman spectrometer to detect Raman signal, the excitation wavelength is 785nm, collect the SERS of azo salt spectrum. Using 10 -6 mol/L azotyrosine as the probe molecule, the Raman signal is the most stable when the probe molecule is in the dry state, as shown in Figure 2. Before 1000s, there is almost no Raman signal. This is because in the initial stage, the nanoparticles in the sol are doing random Brownian motion, and they are in a wet state at this time; the Raman intensity reaches the maximum at 1500s, but then the Raman intensity The time of this process is too short to accurately measure the signal of the probe molecule; when standing for 1500s, the Raman signal is the strongest, and after 2000s, the Raman signal of the probe molecule is in a stable state, and the peak intensity is at a plateau. Then fluctuate, at this time in a dry state.
实施例2Example 2
(1)水热法制备立方纳米银(1) Preparation of cubic nano-silver by hydrothermal method
首先配置银氨溶液,取0.01mol/L的硝酸银水溶液,滴加稀氨水2%(质量分数,下同)溶液从澄清到沉淀再到沉淀恰好消失为止。5mL配好的银氨溶液和5mL十六烷基三甲基溴化铵(20mmol/L)再加上10mL葡萄糖溶液(10mmol/L),充分搅拌混合均匀后倒入25mL的水热反应釜中,将反应釜置于烘箱中120℃反应8h,反应结束后自然冷却至室温,通过10000rpm离心20min,洗涤三次,除去多余的十六烷基三甲基溴化铵,得到直径为50nm,颗粒大小均匀的立方纳米银,如图1所示。First configure silver ammonia solution, take 0.01mol/L silver nitrate aqueous solution, add dropwise dilute ammonia water 2% (mass fraction, the same below) solution from clarification to precipitation until the precipitation just disappears. 5mL silver ammonia solution and 5mL cetyltrimethylammonium bromide (20mmol/L) plus 10mL glucose solution (10mmol/L), fully stirred and mixed evenly, poured into a 25mL hydrothermal reaction kettle , put the reaction kettle in an oven at 120°C for 8 hours, cool down to room temperature naturally after the reaction, centrifuge at 10,000 rpm for 20 minutes, wash three times, remove excess cetyltrimethylammonium bromide, and obtain a particle with a diameter of 50nm and a particle size of Uniform cubic nanosilver, as shown in Figure 1.
(2)酪氨酸的重氮偶联反应(2) Diazo coupling reaction of tyrosine
在冰浴中,首先取1mL对氨基苯硫酚(10-3mol/L)于试管中,加1mL亚硝酸钠水溶液(5%),搅拌1min,然后将1mL碳酸钠(8%)与2mL不同浓度的酪氨酸(10-6mol/L,10-7mol/L,10-8mol/L,10-9mol/L,10-10mol/L,10-11mol/L,10-12mol/L)同时快速加进试管中搅拌反应1min,生成偶氮染料。In an ice bath, first take 1 mL of p-aminothiophenol (10 -3 mol/L) in a test tube, add 1 mL of sodium nitrite aqueous solution (5%), stir for 1 min, then mix 1 mL of sodium carbonate (8%) with 2 mL Different concentrations of tyrosine (10 -6 mol/L, 10 -7 mol/L, 10 -8 mol/L, 10 -9 mol/L, 10 -10 mol/L, 10 -11 mol/L, 10 -12 mol/L) was quickly added into the test tube and stirred for 1 min to generate azo dyes.
(3)酪氨酸浓度的测定(3) Determination of tyrosine concentration
取1.5μL偶氮化的酪氨酸与立方纳米银混合后滴加在超疏水银膜上,静置1500s后,使用雷尼绍拉曼光谱仪进行拉曼信号的检测,激发波长为785nm,采集偶氮盐的SERS光谱,如图3所示,测定不同浓度的酪氨酸的表面增强拉曼光谱。如图4所示,随着酪氨酸浓度逐渐增加,其对应的拉曼光谱信号也逐渐增强,根据偶氮化合物的特征峰1142±2cm-1,1393±2cm-1,1432±2cm-1与酪氨酸浓度的关系绘制标准曲线。如图5所示,各特征峰的浓度与信号强度的线性拟合度较好,其中以1432±2cm-1处特征峰绘制的标准曲线线性拟合度最好。Take 1.5 μL of azotized tyrosine mixed with cubic nano-silver and drop it on the super-hydrophobic silver film. After standing for 1500s, use the Renishaw Raman spectrometer to detect the Raman signal. The excitation wavelength is 785nm. The SERS spectrum of the azo salt is shown in Figure 3, and the surface-enhanced Raman spectrum of different concentrations of tyrosine is measured. As shown in Figure 4, as the concentration of tyrosine gradually increases, the corresponding Raman spectrum signal also gradually increases, according to the characteristic peaks of azo compounds 1142±2cm -1 , 1393±2cm -1 , 1432±2cm -1 Draw a standard curve with respect to the concentration of tyrosine. As shown in Figure 5, the linear fitting degree between the concentration and signal intensity of each characteristic peak is good, and the standard curve drawn with the characteristic peak at 1432±2cm -1 has the best linear fitting degree.
实施例3Example 3
(1)水热法制备立方纳米银(1) Preparation of cubic nano-silver by hydrothermal method
首先配置银氨溶液,取0.01mol/L的硝酸银水溶液,滴加稀氨水2%(质量分数,下同)溶液从澄清到沉淀再到沉淀恰好消失为止。5mL配好的银氨溶液和5mL十六烷基三甲基溴化铵(30mmol/L)再加上10mL葡萄糖溶液(5mmol/L),充分搅拌混合均匀后倒入25mL的水热反应釜中,将反应釜置于烘箱中120℃反应8h。反应结束后自然冷却至室温,通过10000rpm离心20min,洗涤三次,除去多余的十六烷基三甲基溴化铵。得到直径为75nm,颗粒大小均匀的立方纳米银,如图1所示。First configure silver ammonia solution, take 0.01mol/L silver nitrate aqueous solution, add dropwise dilute ammonia water 2% (mass fraction, the same below) solution from clarification to precipitation until the precipitation just disappears. 5mL silver ammonia solution and 5mL cetyltrimethylammonium bromide (30mmol/L) plus 10mL glucose solution (5mmol/L), fully stirred and mixed evenly, poured into a 25mL hydrothermal reaction kettle , put the reactor in an oven at 120°C for 8h. After the reaction was completed, it was naturally cooled to room temperature, centrifuged at 10,000 rpm for 20 min, and washed three times to remove excess cetyltrimethylammonium bromide. A cubic nanosilver with a diameter of 75nm and uniform particle size was obtained, as shown in FIG. 1 .
(2)酪氨酸的重氮偶联反应(2) Diazo coupling reaction of tyrosine
在冰浴中,首先取1mL对氨基苯硫酚(10-3mol/L)于试管中,加1mL亚硝酸钠水溶液(8%),搅拌3min.然后将1mL碳酸钠(10%)与2mL不同浓度的酪氨酸(10-6mol/L,10-7mol/L,10-8mol/L,10-9mol/L,10-10mol/L,10-11mol/L,10-12mol/L)同时快速加进试管中搅拌反应1min,生成偶氮染料。In an ice bath, first take 1mL of p-aminothiophenol (10 -3 mol/L) in a test tube, add 1mL of sodium nitrite aqueous solution (8%), and stir for 3min. Then mix 1mL of sodium carbonate (10%) with 2mL Different concentrations of tyrosine (10 -6 mol/L, 10 -7 mol/L, 10 -8 mol/L, 10 -9 mol/L, 10 -10 mol/L, 10 -11 mol/L, 10 -12 mol/L) was quickly added into the test tube and stirred for 1 min to generate azo dyes.
(3)酪氨酸浓度的测定(3) Determination of tyrosine concentration
取1.5μL偶氮化的酪氨酸与立方纳米银混合后滴加在超疏水银膜上,静置1500s后,使用雷尼绍拉曼光谱仪进行拉曼信号的检测,激发波长为785nm,采集偶氮盐的SERS光谱。Take 1.5 μL of azotized tyrosine mixed with cubic nano-silver and drop it on the super-hydrophobic silver film. After standing for 1500s, use the Renishaw Raman spectrometer to detect the Raman signal. The excitation wavelength is 785nm. SERS spectra of azo salts.
应用实施例1检测尿液中酪氨酸的含量Application Example 1 detects the content of tyrosine in urine
在该应用中,前面的步骤与实施例2中的步骤(1)相同。In this application, the preceding steps are the same as step (1) in Example 2.
(1)取健康青年的尿液样,用不同浓度的酪氨酸溶液稀释为10-4mol/L,10-5mol/L,10-6mol/L,10-7mol/L,10-8mol/L。在冰浴中,首先取1mL对氨基苯硫酚(10-3mol/L)于试管中,加1mL亚硝酸钠水溶液(5%),搅拌1min。然后将1mL碳酸钠(10%)与2mL不同浓度的酪氨酸尿液溶液(10-4mol/L,10-5mol/L,10-6mol/L,10-7mol/L,10-8mol/L)同时快速加入试管中搅拌1min,生成偶氮染料,同时直接制备空白健康青年的尿液作为对照。(1) Take urine samples from healthy young people and dilute them with different concentrations of tyrosine solutions to 10 -4 mol/L, 10 -5 mol/L, 10 -6 mol/L, 10 -7 mol/L, 10 -8 mol/L. In an ice bath, first take 1 mL of p-aminothiophenol (10 -3 mol/L) in a test tube, add 1 mL of sodium nitrite aqueous solution (5%), and stir for 1 min. Then 1 mL of sodium carbonate (10%) was mixed with 2 mL of tyrosine urine solution of different concentrations (10 -4 mol/L, 10 -5 mol/L, 10 -6 mol/L, 10 -7 mol/L, 10 -8 mol/L) was quickly added to the test tube and stirred for 1 min to generate an azo dye, and the urine of a blank healthy youth was directly prepared as a control.
(2)取1.5μL尿液中偶氮化的酪氨酸与1.5μL立方纳米银混合后滴加在超疏水银膜上,使用雷尼绍拉曼光谱仪进行拉曼信号的检测,激发波长为785nm,采集尿液中酪氨酸偶氮盐的SERS光谱。如图6所示,从图中可见,直接检测空白尿液,偶氮化合物拉曼信号不明显,但是还存在,说明正常人尿液中也存在着微量的酪氨酸;而加入不同浓度酪氨酸后的尿液可以观测到明显的偶氮化合物的拉曼信号,表明该方法可应用于尿液中的酪氨酸的分析检测。如图7所示,1393±2cm-1特征峰的浓度与拉曼信号强度的线性拟合度较好,说明尿液中的尿素对于酪氨酸的影响较小。为了验证标准曲线的准确性,通过制备在线性范围3个不同浓度的样品进行回收测试,得到相关的SERS信号,然后计算测量浓度与相关浓度的比率,即回收率(%)。回收率实验如列表1所示,通过1393±2cm-1处特征峰绘制的标准曲线计算出的尿液中酪氨酸的回收率,由下表可知,通过下表可知,利用本发明检测的酪氨酸具有较高的灵敏度,且误差较小,回收率高说明利用表面增强拉曼光谱的方法检测尿液中的酪氨酸是可行的。(2) Mix 1.5 μL of azotized tyrosine in urine with 1.5 μL of cubic nano-silver and drop it on the super-hydrophobic silver film. Use Renishaw Raman spectrometer to detect the Raman signal. The excitation wavelength is 785nm, collect the SERS spectrum of tyrosine azo salt in urine. As shown in Figure 6, it can be seen from the figure that when the blank urine is directly detected, the Raman signal of the azo compound is not obvious, but it still exists, indicating that there is also a small amount of tyrosine in the urine of normal people; while adding different concentrations of tyrosine Obvious Raman signals of azo compounds can be observed in the urine after tyrosine, indicating that the method can be applied to the analysis and detection of tyrosine in urine. As shown in Figure 7, the linear fit between the concentration of the characteristic peak at 1393±2cm -1 and the intensity of the Raman signal is good, indicating that urea in urine has little effect on tyrosine. In order to verify the accuracy of the standard curve, the recovery test was carried out by preparing samples with 3 different concentrations in the linear range to obtain the relevant SERS signal, and then calculate the ratio of the measured concentration to the relevant concentration, that is, the recovery (%). The recovery rate experiment is as shown in list 1, and the recovery rate of tyrosine in the urine calculated by the standard curve drawn by the characteristic peak at 1393 ± 2cm-1 can be seen from the following table. Tyrosine has high sensitivity and small error, and the high recovery rate shows that it is feasible to detect tyrosine in urine by surface-enhanced Raman spectroscopy.
表1是尿液中酪氨酸回收率的测试Table 1 is the test of the recovery rate of tyrosine in urine
以上所述仅为本发明的实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书内容所作的等效结构或等效流程变换,或直接或间接运用在其他相关的技术领域,均同理包括在本发明的专利保护范围内。The above is only an embodiment of the present invention, and does not limit the patent scope of the present invention. Any equivalent structure or equivalent process conversion made by using the content of the description of the present invention, or directly or indirectly used in other related technical fields, shall be The same reasoning is included in the patent protection scope of the present invention.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810611783.5A CN109001177A (en) | 2018-06-14 | 2018-06-14 | The detection method of tyrosine in a kind of urine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810611783.5A CN109001177A (en) | 2018-06-14 | 2018-06-14 | The detection method of tyrosine in a kind of urine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109001177A true CN109001177A (en) | 2018-12-14 |
Family
ID=64601935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810611783.5A Withdrawn CN109001177A (en) | 2018-06-14 | 2018-06-14 | The detection method of tyrosine in a kind of urine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109001177A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109342391A (en) * | 2018-11-03 | 2019-02-15 | 华东理工大学 | Detection method of tyrosinase activity based on recyclable SERS sensor |
| CN110618124A (en) * | 2019-09-17 | 2019-12-27 | 宁波大学 | Method for detecting content of tyramine in aquatic product based on azo coupling reaction and surface enhanced resonance Raman scattering |
| CN111157512A (en) * | 2020-02-17 | 2020-05-15 | 福建师范大学 | SERS substrate for detecting tyrosinase activity and method for detecting tyrosinase activity by using same |
| CN114685311A (en) * | 2020-12-29 | 2022-07-01 | 华中师范大学 | An azo aromatic compound and its application and a reagent for enhancing Raman scattering signal |
| CN115290626A (en) * | 2022-07-08 | 2022-11-04 | 四川大学 | Method for detecting histamine by SERS based on combination of hydrophobic substrate and azo reaction |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101022799A (en) * | 2004-07-19 | 2007-08-22 | 约翰·霍普金斯大学 | FLT3 Inhibitors for Immunosuppression |
| WO2010114375A1 (en) * | 2009-04-01 | 2010-10-07 | River Diagnostics B.V. | Method for determination of unknown mutations |
| CN102608099A (en) * | 2012-02-29 | 2012-07-25 | 哈尔滨工业大学 | Method for preparing surface-enhanced Raman spectroscopy substrate of silver self-assembly under assistance of amino acids |
| EP2518474A1 (en) * | 2011-04-27 | 2012-10-31 | Well Dynamics Applications S.r.l. WDA | Method for the determination of analytes in the hair |
| CN104119244A (en) * | 2014-06-27 | 2014-10-29 | 上海师范大学 | DL tyrosine chiral resolution and on-line detection method based on functional nano channel arrays |
| CN105842219A (en) * | 2016-05-24 | 2016-08-10 | 陕西师范大学 | Tyrosinase-assisted fluorescence enhanced tyrosine protein kinase activity analysis method |
| CN106053575A (en) * | 2016-08-12 | 2016-10-26 | 浙江大学 | Composite material-modified electrode used for measuring tyrosine concentration and application thereof |
| CN106124477A (en) * | 2016-06-21 | 2016-11-16 | 东南大学 | A kind of nanometer silver course of dissolution discharges concentration of silver ions and the detection method of speed |
| CN106990155A (en) * | 2017-06-07 | 2017-07-28 | 广西师范学院 | The method for detecting tyrosine concentration in solution |
| EP3105240A4 (en) * | 2014-03-15 | 2017-08-02 | Wake Forest University | Functionalized tyrosine kinase inhibitors modified with precious metal electrophiles and methods associated therewith |
-
2018
- 2018-06-14 CN CN201810611783.5A patent/CN109001177A/en not_active Withdrawn
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101022799A (en) * | 2004-07-19 | 2007-08-22 | 约翰·霍普金斯大学 | FLT3 Inhibitors for Immunosuppression |
| WO2010114375A1 (en) * | 2009-04-01 | 2010-10-07 | River Diagnostics B.V. | Method for determination of unknown mutations |
| EP2518474A1 (en) * | 2011-04-27 | 2012-10-31 | Well Dynamics Applications S.r.l. WDA | Method for the determination of analytes in the hair |
| CN102608099A (en) * | 2012-02-29 | 2012-07-25 | 哈尔滨工业大学 | Method for preparing surface-enhanced Raman spectroscopy substrate of silver self-assembly under assistance of amino acids |
| EP3105240A4 (en) * | 2014-03-15 | 2017-08-02 | Wake Forest University | Functionalized tyrosine kinase inhibitors modified with precious metal electrophiles and methods associated therewith |
| CN104119244A (en) * | 2014-06-27 | 2014-10-29 | 上海师范大学 | DL tyrosine chiral resolution and on-line detection method based on functional nano channel arrays |
| CN105842219A (en) * | 2016-05-24 | 2016-08-10 | 陕西师范大学 | Tyrosinase-assisted fluorescence enhanced tyrosine protein kinase activity analysis method |
| CN106124477A (en) * | 2016-06-21 | 2016-11-16 | 东南大学 | A kind of nanometer silver course of dissolution discharges concentration of silver ions and the detection method of speed |
| CN106053575A (en) * | 2016-08-12 | 2016-10-26 | 浙江大学 | Composite material-modified electrode used for measuring tyrosine concentration and application thereof |
| CN106990155A (en) * | 2017-06-07 | 2017-07-28 | 广西师范学院 | The method for detecting tyrosine concentration in solution |
Non-Patent Citations (3)
| Title |
|---|
| MIN-LIANG CHENG: "Silver nanoparticle-treated filter paper as a highly sensitive surface-enhanced", 《ANALYTICA CHIMICA ACTA》 * |
| YUDONG LU: "Diazotization-Coupling Reaction-Based", 《NANOMATERIALS》 * |
| 支小平: "高效液相色谱-串联质谱法同时测定", 《南昌大学学报(理科版)》 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109342391A (en) * | 2018-11-03 | 2019-02-15 | 华东理工大学 | Detection method of tyrosinase activity based on recyclable SERS sensor |
| CN109342391B (en) * | 2018-11-03 | 2021-03-30 | 华东理工大学 | Detection method of tyrosinase activity based on recyclable SERS sensor |
| CN110618124A (en) * | 2019-09-17 | 2019-12-27 | 宁波大学 | Method for detecting content of tyramine in aquatic product based on azo coupling reaction and surface enhanced resonance Raman scattering |
| CN111157512A (en) * | 2020-02-17 | 2020-05-15 | 福建师范大学 | SERS substrate for detecting tyrosinase activity and method for detecting tyrosinase activity by using same |
| CN114685311A (en) * | 2020-12-29 | 2022-07-01 | 华中师范大学 | An azo aromatic compound and its application and a reagent for enhancing Raman scattering signal |
| CN114685311B (en) * | 2020-12-29 | 2024-06-04 | 华中师范大学 | Azo aromatic compound, application thereof and reagent for enhancing Raman scattering signal |
| CN115290626A (en) * | 2022-07-08 | 2022-11-04 | 四川大学 | Method for detecting histamine by SERS based on combination of hydrophobic substrate and azo reaction |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109001177A (en) | The detection method of tyrosine in a kind of urine | |
| Qu et al. | Highly selective and sensitive surface enhanced Raman scattering nanosensors for detection of hydrogen peroxide in living cells | |
| Li et al. | Dual-modal visual/photoelectrochemical all-in-one bioassay for rapid detection of AFP using 3D printed microreactor device | |
| CN113155807A (en) | MicroRNA (ribonucleic acid) ultrasensitive detection method based on surface enhanced Raman spectroscopy | |
| Luo et al. | Catalytic hairpin assembly-mediated SERS biosensor for double detection of MiRNAs using gold nanoclusters-doped COF substrate | |
| Shariati et al. | The colorimetric and microfluidic paper-based detection of cysteine and homocysteine using 1, 5-diphenylcarbazide-capped silver nanoparticles | |
| CN104122247B (en) | Glycoprotein detection method based on molecular imprinting technique and Raman spectrum and application | |
| CN110412291A (en) | A method of building SERS spectra probe in detecting markers for breast cancer EGFR phosphorylated tyrosine | |
| CN113138185B (en) | Detection of sodium thiocyanate in milk by MOF-based SERS technology | |
| CN109239046B (en) | C-reactive protein detection reagent and SERS detection method | |
| CN110455769B (en) | Quantitative analysis method of surface-enhanced Raman spectroscopy of core-shell nanoparticles with shell as internal standard | |
| CN113136417A (en) | Gold nanocage SERS sensor for detecting lung cancer marker and preparation method thereof | |
| Wang et al. | Combining multisite functionalized magnetic nanomaterials with interference-free SERS nanotags for multi-target sepsis biomarker detection | |
| CN102175664A (en) | Method for detecting surface enhanced Raman spectra of blood RNA | |
| CN108037108A (en) | A kind of method of thiocyanate ion content in new measure actual sample | |
| Zheng et al. | Silver nanoparticles/activated carbon composite as a facile SERS substrate for highly sensitive detection of endogenous formaldehyde in human urine by catalytic reaction | |
| Bahavarnia et al. | Microfluidic paper-based colorimetric quantification of malondialdehyde using silver nanoprism toward on-site biomedical analysis: a new platform for the chemical sensing and biosensing of oxidative stress | |
| CN110987896A (en) | Trace amoxicillin detection method taking Ag @ Au as SERS substrate | |
| Luo et al. | A combined surface-enhanced Raman spectroscopy (SERS)/colorimetric approach for the sensitive detection of malondialdehyde in biological samples | |
| Sun et al. | A novel surface-enhanced Raman scattering method for simultaneous detection of ketamine and amphetamine | |
| Ruan et al. | Determination of H2O2 and its antioxidant activity by BCM@ Au NPs ratiometric SERS sensor | |
| CN116500014B (en) | Method for simultaneously and quantitatively detecting concentration of uric acid and creatinine in complex matrix based on paper chromatography and surface-enhanced Raman scattering technology | |
| Lu et al. | Ratiometric SERS quantitative analysis of tyrosinase activity based on gold-gold hybrid nanoparticles with Prussian blue as an internal standard | |
| Zhang et al. | Gold bipyramids molecularly imprinted gel colorimetric device for whole blood cholesterol analysis | |
| CN115791750B (en) | Preparation method and application of hydrogel flexible SERS substrate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20181214 |